Overview

Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?

Status:
Terminated

Trial end date:
2014-01-01

Target enrollment:

Participant gender:

Summary

Ovarian hyperstimulation syndrome (OHSS) is a major complication of ovarian stimulation for IVF if hCG is used to trigger final oocyte maturation. The investigators propose that using GnRH agonist as a trigger will eliminate OHSS, even in high-risk patients.

Phase:

Phase 4

Details

Lead Sponsor:

Elisha Hospital

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Deslorelin
Triptorelin Pamoate